The Cancer Prognostics and Health Outcomes Unit of the University of Montreal, directed by Dr. Pierre Karakiewicz, in collaboration with several centers of excellence from around the world has developed a series of computerized devices to help patients and their physicians decide among the major treatment choices for several cancers and non-malignant conditions. The available applications, developed by Pierre Karakiewicz et al., can be used in prostate, bladder, kidney, adrenal and penile cancers, as well as in renal transplantation. Click here to access nomograms.

Bladder Cancer

Here is a list of available Bladder Cancer nomograms:

Available nomograms for prediction of Bladder Cancer

• BCa diagnosis - To predict the risk of bladder cancer.
• Non-muscular invasive BC - To predict the probability of recurrence in individuals with non-muscle.
• Advanced T-stage (pT3+) - To predict the probability of extra-vesical extension at radical cystectomy pathologic stage T3 or higher.
• Advanced N-stage (pN+) - To predict the probability of nodal metastases at cystectomy (pathologic stage N1-3).
• BCa recurrence - To predict the probability of BCa recurrence after cystectomy.
• BCa-specific Mortality - To predict the probability of BCa death after cystectomy.
• All-cause Mortality - To predict the probability of all-cause death after cystectomy.

Click here to access nomograms.